logo
logo

Genemod Raises $4.5M To Become The Central Research Platform For Biopharma Companies

May 04, 2023•about 2 years ago

Amount Raised

$4.5 Million

Round Type

seed

SeattleBiotechnology

Investors

Vulcan/Cercano VenturesDolby Family VenturesLdv PartnersDefy.Vc

Description

Genemod, a cloud-based workspace collaboration software for biopharma R&D teams, today announced it raised $4.5 million in seed funding, co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures.

Company Information

Company

Genemod Corp

Location

8026 238TH ST SW

Seattle, Washington, United States

About

Genemod accelerates life sciences R&D by improving collaboration for every team in a hybrid workspace so that scientists can work on big ideas, without the busywork. We bring your team’s work together in one shared space. Improve process management by leaving the repetitive stuff to us so you can do more of the work you do best.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers